Skip to content
Company Analysis

OptimizeRx Corporation OPRX

A comprehensive view of key metrics, scores, and financial health for OptimizeRx Corporation

Overview of OptimizeRx Corporation

OPRX NCM
Healthcare Health Information Services Framework: General Corporate Micro Cap
OptimizeRx Corporation (OPRX), is a Micro Cap company, in the Health Information Services industry, last closed at $5.23, about 128.1% undervalued vs fair value, -63.3% 1Y return, placing in the top 25% of its sector.
USD 5.23
-0.95%
(Delayed)
• Vol 90d: 82.9%
52-Week Range
Market Cap
$95.30M
Enterprise Value
$98.85M
Overall Score
View breakdown
Overall
Growth
Good
Profitability
Good
Health
Fair
Efficiency
Fair
Valuation
Good
Growth
Good
Profitability
Good
Health
Fair
Efficiency
Fair
Valuation
Good
Completeness: 82%
Confidence: 89%
Updated: Mar 8
Top Beats

Quick Facts

Website https://www.optimizerx.com
HQ Waltham, MA
Employees 128
Fiscal year Dec 31

Next Events

Earnings Aug 6 Estimated

Fair Value Snapshot

Bear Base Bull
$11
$12
$13
Current: $5.23 +128% vs base

Engine Room Money Flow™

Micro Cap

Corporate Free Cash Flow - Where revenue goes and how value is created

Flow Steps
Revenue
$109.4M
18.8%%
Gross Profit
$73.6M
23.9%%
Operating Income
$12.1M
294%%
Net Income
$5.1M
125.5%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Corporate Free Cash Flow

Quality & Reliability Indicators

Cash Conversion Ratio
364.7%
Excellent

FCF / Net Income - measures how well earnings convert to cash

Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium

Where It Leaks

Cash Flow Health some concerns
Moderate efficiency issues detected. Review active leaks below for improvement areas.
3
Active Leaks
2/3
Improving
1
High Impact
0
Critical
Locked Leak
Upgrade to view details
Premium
Locked Leak
Upgrade to view details
Premium
Moat Analysis Corporate Default

Competitive Advantage Assessment

Evaluating OptimizeRx Corporation's durable competitive advantages across 6 defense dimensions

Overall Moat Strength
43
/100
Developing
Scores based on quantitative metrics and qualitative factors

Upgrade to unlock interactive defense details

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power

Developing
49
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

Generic Industrial / Default vs Industry Peers 88% Coverage
Trade-Off Triangle Visualization A ternary plot showing OPRX's balance between Growth (43.1%), Profitability (22.5%), and Safety (34.4%). Growth 43% Safety 34% Profitability 22%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

70th percentile vs peers
71
Key Signals
Rev Growth YoY 28.8% 87p Revenue CAGR 3Y 14.5% 75p EPS Growth YoY -7.2% 39p
Strengths
  • Rev Growth YoY in top 20% of peers (28.8%, 87th percentile)
  • Growth above peer median with strong metric coverage (75%)
  • Gross Profit Margin in top 20% of peers (64.5%, 87th percentile)
  • Quick Ratio in top 20% of peers (11.53, 97th percentile)
  • Strong liquidity position vs peers
Risks

No significant risks identified for this axis.

Profitability

36th percentile vs peers
37
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

56th percentile vs peers
56
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for OptimizeRx Corporation.

Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
$11.93
- - -
+128.1% vs current
Snapshot base estimate
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info
Send Feedback
Please select a category.
0/1000